--2025/Q1-- / 7.260M--
--2024/Q4-- / 4.280M--
--2024/Q34.894M / 3.600M--
--2024/Q24.831M / 3.256M--
--2024/Q14.216M / 3.214M--
Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 7.850
- -0.140-1.75%
Close Feb 28 16:00 ET
- 7.850
- 0.0000.00%
Post 20:01 ET
415.79MMarket Cap-3.77P/E (TTM)
8.134High7.770Low691.63KVolume7.980Open7.990Pre Close5.46MTurnover1.92%Turnover RatioLossP/E (Static)52.97MShares17.58052wk High1.79P/B283.40MFloat Cap5.60052wk Low--Dividend TTM36.10MShs Float71.580Historical High--Div YieldTTM4.55%Amplitude3.350Historical Low7.888Avg Price1Lot Size
Stoke Therapeutics Key Stats
Stoke Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Stoke Therapeutics Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data